SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-028341
Filing Date
2007-04-13
Accepted
2007-04-13 17:20:38
Documents
5
Period of Report
2007-04-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-10544_18k.htm 8-K 22507
2 EX-99.1 a07-10544_1ex99d1.htm EX-99.1 5404
3 EX-99.2 a07-10544_1ex99d2.htm EX-99.2 6325
4 GRAPHIC g105441mai001.jpg GRAPHIC 2778
5 GRAPHIC g105441mci001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-07-028341.txt   43819
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 07766666
SIC: 2835 In Vitro & In Vivo Diagnostic Substances